Fondation de France   Report issue

Foundation Phase 3 Phase 4
Founded: Paris France (1969)

Organization Overview

First Clinical Trial
2007
NCT00273741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now